My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 198

    1.

    Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians.

    Coley CM, Barry MJ, Fleming C, Fahs MC, Mulley AG.

    Ann Intern Med. 1997 Mar 15;126(6):468-79.PMID: 9072935 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians.

    Coley CM, Barry MJ, Fleming C, Mulley AG.

    Ann Intern Med. 1997 Mar 1;126(5):394-406. Review.PMID: 9054286 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.

    Littrup PJ, Goodman AC, Mettlin CJ.

    CA Cancer J Clin. 1993 May-Jun;43(3):134-49.PMID: 7683964 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Cost analyses of prostate cancer screening: frameworks for discussion. Investigators of the American Cancer Society-National Prostate Cancer Detection Project.

    Littrup PJ, Goodman AC, Mettlin CJ, Murphy GP.

    J Urol. 1994 Nov;152(5 Pt 2):1873-7.PMID: 7523734 [PubMed - indexed for MEDLINE]Related articles

    5.

    Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force.

    Harris R, Lohr KN.

    Ann Intern Med. 2002 Dec 3;137(11):917-29. Review.PMID: 12458993 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Screening for prostate cancer. A decision analytic view.

    Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS.

    JAMA. 1994 Sep 14;272(10):773-80.PMID: 7521400 [PubMed - indexed for MEDLINE]Related articles

    7.

    Cost-effectiveness analysis in early detection of prostate cancer: an evaluation of six screening strategies in a randomly selected population of 2,400 men.

    Gustafsson O, Carlsson P, Norming U, Nyman CR, Svensson H.

    Prostate. 1995 Jun;26(6):299-309.PMID: 7540297 [PubMed - indexed for MEDLINE]Related articles

    8.

    A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

    Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

    Health Technol Assess. 2001;5(28):1-110. Review.PMID: 11701100 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The socioeconomic implications of prostate-specific antigen screening.

    Benoit RM, Naslund MJ.

    Urol Clin North Am. 1997 May;24(2):451-8. Review.PMID: 9126243 [PubMed - indexed for MEDLINE]Related articles

    10.

    Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma.

    Mistry K, Cable G.

    J Am Board Fam Pract. 2003 Mar-Apr;16(2):95-101.PMID: 12665174 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

    Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

    Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.PMID: 18678846 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Screening for prostate cancer.

    Ilic D, O'Connor D, Green S, Wilt T.

    Cochrane Database Syst Rev. 2006 Jul 19;3:CD004720. Review.PMID: 16856057 [PubMed - indexed for MEDLINE]Related articles

    13.

    Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.

    Candas B, Cusan L, Gomez JL, Diamond P, Suburu RE, Lévesque J, Brousseau G, Bélanger A, Labrie F.

    Prostate. 2000 Sep 15;45(1):19-35.PMID: 10960839 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prostate cancer screening: what we know and what we need to know.

    Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK.

    Ann Intern Med. 1993 Nov 1;119(9):914-23.PMID: 7692780 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Voluntary screening program for prostate cancer: detection rate and cost.

    Abramson N, Cotton S, Eckels R, Baldock J.

    South Med J. 1994 Aug;87(8):785-8.PMID: 7519789 [PubMed - indexed for MEDLINE]Related articles

    16.

    Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.

    Ross KS, Carter HB, Pearson JD, Guess HA.

    JAMA. 2000 Sep 20;284(11):1399-405.PMID: 10989402 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Costs and benefits of prostate cancer screening. Investigators of the American Cancer Society--National Prostate Cancer Detection Project.

    Littrup PJ, Goodman AC.

    In Vivo. 1994 May-Jun;8(3):423-7. Review.PMID: 7803728 [PubMed - indexed for MEDLINE]Related articles

    18.

    Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.

    Krahn MD, Coombs A, Levy IG.

    CMAJ. 1999 Jan 12;160(1):49-57.PMID: 9934343 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Delays in cancer detection using 2 and 4-year screening intervals for prostate cancer screening with initial prostate specific antigen less than 2 ng/ml.

    Kundu SD, Grubb RL, Roehl KA, Antenor JA, Han M, Catalona WJ.

    J Urol. 2005 Apr;173(4):1116-20.PMID: 15758718 [PubMed - indexed for MEDLINE]Related articles

    20.

    Unanswered questions in screening for prostate cancer.

    Neal DE, Leung HY, Powell PH, Hamdy FC, Donovan JL.

    Eur J Cancer. 2000 Jun;36(10):1316-21. Review.PMID: 10882874 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity